Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Suppression of visceral nociception by C-fiber transmission block using temporal interference sinusoidal stimulation
Pain Reports
August 2026
Chen L.
Open Access
Duloxetine as a gut-brain axis modulator in irritable bowel syndrome: neuroimmune, microbiota, and pharmacogenomic perspectives
Naunyn Schmiedeberg S Archives of Pharmacology
August 2026
Rejili M.
Effects of Electroacupuncture at ST36 on Visceral Pain and Inflammatory Markers in IBS Rats
Neurogastroenterology and Motility
May 2026
Hao Y.b.
Open Access
The Gut—Brain Axis and Visceral Hyperalgesia: the Supraspinal Neuronal Mechanisms
Uspekhi Fiziologicheskikh Nauk
2026
Lyubashina O.A.
Pain management in a patient with intestinal failure in the palliative care setting: case report
BMC Palliative Care
December 2025
Das A.
Open Access
Comparisons of different electrical stimulation modalities for treating visceral pain in a rodent model of irritable bowel syndrome
Bioelectronic Medicine
December 2024
Alam M.J.
Open Access
Rifaximin and alternative agents in the management of irritable bowel syndrome: A comprehensive review
Archiv Der Pharmazie
October 2024
Deljavan Ghodrati A.
Mixed probiotics reduce the severity of stress-induced depressive-like behaviors
Journal of Affective Disorders
15 June 2024
Li X.
Complex visceral hyperalgesia in an adolescent with Pitt-Hopkins syndrome
BMJ Case Reports
19 February 2024
Reaney L.
All Open Access, Green
Blocking Aδ- and C-fiber neural transmission by sub-kilohertz peripheral nerve stimulation
Frontiers in Neuroscience
2024
Zhang S.
Open Access
Optimizing Pain Management in Palliative Care for a Patient with Intestinal Failure: A Case Report
Journal of Integrative Nursing and Palliative Care
2024
Suhail H.
Open Access
Evaluation of the mechanism of action of paracetamol, drotaverine, and peppermint oil and their effects in combination with hyoscine butylbromide on colonic motility: human ex-vivo study
Frontiers in Pharmacology
2024
Traserra S.
Open Access
Systematic Review on Herbal Preparations for Controlling Visceral Hypersensitivity in Functional Gastrointestinal Disorders
Current Pharmaceutical Biotechnology
2024
Lashgari N.A.
Efficacy and safety of olorinab, a full agonist of the cannabinoid receptor 2, for the treatment of abdominal pain in patients with irritable bowel syndrome: Results from a phase 2b randomized placebo-controlled trial (CAPTIVATE)
Neurogastroenterology and Motility
May 2023
Chang L.
Open Access
Pharmacological approaches to treat intestinal pain
Expert Review of Clinical Pharmacology
2023
Swierczynski M.
Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study
Pediatric Drugs
January 2023
Vázquez-Frias R.
Open Access
Editorial: Emerging trends in abdominal and pelvic pain
Frontiers in Pain Research
2023
Feng B.
Open Access
An overview of 5-HT3 receptor antagonists as a treatment option for irritable bowel syndrome with diarrhea
Expert Opinion on Pharmacotherapy
2023
Merecz K.
Long-lasting visceral hypersensitivity in a model of DSS-induced colitis in rats
Neurogastroenterology and Motility
November 2022
López-Estévez S.
Open Access
Somatosensory Profiles Differentiate Pain and Psychophysiological Symptoms among Young Adults with Irritable Bowel Syndrome: A Cluster Analysis
Clinical Journal of Pain
16 July 2022
Chen J.
All Open Access, Green
Blocking peripheral drive from colorectal afferents by subkilohertz dorsal root ganglion stimulation
Pain
1 April 2022
Chen L.
All Open Access, Green
Evaluation and Management Strategies for GI Involvement with Amyloidosis
American Journal of Medicine
April 2022
Fritz C.D.L.
Antispasmodic Effect of Bergamot Essential Oil on Rat Isolated Gut Tissues
Pharmaceutics
April 2022
Rombolà L.
Open Access